Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

The tech-heavy Nasdaq sustained a 2.2% drop, while the S&P 500 fell 1.3%. Both ended up slightly below their 21-day ...

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article, we ...

STACKER — Research shows that comprehensive sex education reduces teen birth rates and sexually transmitted infections, ...